Moving the Industry Towards Increased Patient Access

The Pre-approval Access Programs conference offers the chance to benchmark with key opinion leaders, connect with like-minded peers, and share different perspectives. This extensive program will highlight the most challenging regulatory requirements and best practices in creating a streamlined pre-approval access program.

Global access and regulatory compliance are the strongest drivers of pre-approval access programs from big pharma to small biotech. With the number of patients in need of new therapies to tackle their rare diseases growing, the public is clamoring for programs designed to offer drugs before they have been approved. Slow processes, cumbersome paperwork and the question of liability provide major roadblocks to the enactment of these programs. As awareness grows through social media and recent regulation, the industry must gain momentum in putting together the proper structure to get drugs to market. Join us this September to move the needle forward.

Request Agenda

Why You Can't Miss This

High level Industry discussion and networking

Working towards industry standards

Interactive workshops – Deep dive into industry challenges

Strengthening the relationship between key industry players to accelerate drug development

Featured Speakers

Anne B. Cropp

Chief Scientific Officer
Early Access Care

Ramana Sonty

Director, Global Medical Organization
Johnson & Johnson

Jennifer McNary

Patient Advocate
Beauhawks Foundation

Brian Malkin

FDA Counsel
Arent Fox LLP

Alison Bateman-House

Assistant Professor – Division of Medical Ethics
NYU

Kiran Bhirangi

Head of Medical Affairs
Cardiome Pharma Corp

Naomi Lopez Bauman

Director of Healthcare Policy
Goldwater Institute

Andrew McFadyen

Executive Director
The Isaac Foundation

Rob Friedman

Manager Senior, Clinical Operations
Ventana Medical Systems, Inc

Dane Hartung

Director Marketing and Access
Fougera / PharmaDerm Pharmaceuticals a Division of Novartis

John Lagus

Head of Managed Access
Clinigen Group

James Wilson

Professor, Scientific Founder and Special Advisor
UPenn, Regenxbio

View All Speakers

Advisory Board

View all Members

Sponsors & Exhibitors
Media Partners